Lonza Group AG (LZAGY)
OTCMKTS · Delayed Price · Currency is USD
65.48
+0.24 (0.37%)
Dec 17, 2025, 4:00 PM EST
Lonza Group AG Market Cap
Lonza Group AG has a market cap or net worth of $46.28 billion as of December 17, 2025. Its market cap has increased by 7.34% in one year.
Market Cap
46.28B
Enterprise Value
51.01B
Revenue
8.92B
Ranking
n/a
PE Ratio
50.21
Stock Price
$65.48
Market Cap Chart
Since November 1, 1999, Lonza Group AG's market cap has increased from 3.78B to 46.28B, an increase of 1,124.58%. That is a compound annual growth rate of 10.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 46.28B | 8.47% |
| Dec 30, 2024 | 42.67B | 36.74% |
| Dec 29, 2023 | 31.20B | -14.17% |
| Dec 30, 2022 | 36.35B | -41.26% |
| Dec 30, 2021 | 61.89B | 29.41% |
| Dec 30, 2020 | 47.82B | 76.56% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Glass House Brands | 723.84M |
| Elite Pharmaceuticals | 534.83M |
| CytoDyn | 383.23M |
| Northwest Biotherapeutics | 376.54M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 311.74M |
| Nika Pharmaceuticals | 285.90M |